TXG

10x Genomics Inc.

Price

$95.13

return (12m)

646.08%

p/e

-159.04

p/bv

14.47

DIVIDEND YIELD

0.00%

TXG price

10x Genomics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TXG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

46.39%

3 months

144.19%

1 year

646.08%

2 years

375.15%

5 years

-33.15%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals TXG

Valuation

P/E

-159.04

Sector 1.08

Industry 3.46

P/BV

14.47

Sector 1.87

Industry 2.13

P/Revenue (PSR)

19.37

Sector 1.53

Industry 1.72

EV/EBITDA

-1,636.20

Sector -46.64

Industry 1.72

EV/EBIT

-611.22

Sector -50.35

Industry -4.29

P/EBITDA

379.97

Sector -31.90

Industry -53.68

P/EBIT

-724.31

Sector -43.90

Industry -50.97

P/Total Assets

11.60

Sector 0.85

Industry 0.96

P/Net Current Assets

25.41

Sector -26.05

Industry -11.19

P/Working Capital

21.48

Sector -3.95

Industry 2.92

EPS

-0.58

Sector -0.70

Industry -0.60

BVPS

6.35

Sector 4.48

Industry 4.74

Efficiency

Gross Margin

70.03%

Sector 49.44%

Industry 50.68%

EBITDA Margin

-4.61%

Sector -282.02%

Industry -57.47%

EBIT Margin

-12.34%

Sector -164.03%

Industry -56.25%

Operating Margin

-14.33%

Sector -19.60%

Industry -25.80%

Net Profit Margins

-12.18%

Sector -23.82%

Industry -29.17%

Asset Turnover

0.15

Sector 0.13

Industry 0.15

Profitability

ROE

-9.10%

Sector -23.80%

Industry -22.30%

ROA

-7.29%

Sector -24.22%

Industry -24.15%

ROIC

-20.51%

Sector -587.47%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.69

Sector 1.90

Industry 1.98

Net Debt / EBITDA

79.26

Sector -23.34

Industry -2.21

Net Debt / EBIT

29.61

Sector -11.26

Industry -1.50

Net Debt / Equity

-0.67

Sector -0.63

Industry -0.29

Gross Debt / Equity

0.00

Sector -0.73

Industry -0.82

Equity/Assets

0.80

Sector 0.46

Industry 0.47

Liabilities/Assets

0.20

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

4.69%

Sector -

Industry -

5Y Earnings CAGR

5.23%

Sector -

Industry -

Fundamentals TXG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TXG 10x Genomics Inc.	$95.13	646.08%	0.00%	-159.04	14.47	-9.10%	-12.18%
TMO Thermo Fisher Scientific Inc.	$667.46	23.38%	0.28%	34.69	4.59	13.22%	15.04%
DHR Danaher Corporation	$218.40	2.53%	0.67%	37.74	2.87	7.61%	15.95%
WAT Waters Corporation	$434.77	32.39%	0.00%	251.30	2.75	1.09%	3.58%
IQV IQVIA Holdings Inc.	$263.00	27.28%	0.00%	31.12	6.79	21.82%	8.10%
SHC Sotera Health Company	$18.50	15.96%	0.00%	31.95	7.85	24.56%	13.44%
CGEN Compugen Ltd.	$2.30	40.80%	0.00%	8.06	2.50	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
JNJ Johnson & Johnson	$254.44	37.94%	2.06%	29.27	7.25	24.76%	21.48%
LLY Eli Lilly and Compay	$1,151.00	37.91%	0.59%	38.06	30.01	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$404.44	-10.59%	0.00%	44.62	7.65	17.15%	28.44%
SNY Sanofi	$39.35	-19.65%	4.45%	3.72	0.69	18.43%	14.25%
NVS Novartis AG	$140.31	8.04%	2.22%	20.91	6.36	30.41%	23.29%
ABT Abbott Laboratories	$100.24	-23.33%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$87.83	-6.43%	3.30%	21.10	2.17	10.29%	13.93%
GSK GlaxoSmithKline PLC	$46.51	12.21%	3.77%	14.44	4.08	28.24%	14.54%
CVS CVS Health Corporation	$86.61	16.19%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$42.78	-56.05%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$83.05	-28.21%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$523.96	-16.99%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$223.01	-19.11%	1.12%	20.92	4.84	23.13%	26.94%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TXG - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT 10x Genomics

10x Genomics Inc.

Average Investor10 user rating

4.0 (6 people)

United States

14 years

Founded: 2012

2019

Time since IPO - 7 years

290

Employees

10x Genomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.95 billion, with shareholders equity totaling $825.55 million.

The company employs approximately 290 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, 10x Genomics Inc. reported $616.91 million in revenue, generating net income of $-75.13 million.

Key financial metrics include a P/E ratio of -159.04, a price-to-book (P/B) ratio of 14.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TXG.

Market cap

$11.95 billion

Net worth

$825.55 million

$825,546,000.00

Assets

$1.03 billion

$1,030,066,000.00

Total Shares Outstanding

129.98 million

129,984,000

Average Daily Trading Volume

$3.03 million

$3,029,395.42

Sector

Health

Industry

Life Science Tools and Services

TXG

TXG revenue and profits

Financial Results TXG

DRAG THE FRAME TO SEE MORE DATA

TXG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.61 16,19% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$270.90 --10,93% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$63.47 63,99% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$393.90 41,14% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.35 --19,65% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$254.44 37,94% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,151.00 37,91% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$435.27 1,82% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45